What we do Max Healthcare Institute Limited is a leading Indian healthcare provider operating a network of 22 hospitals and medical centers offering comprehensive secondary and tertiary care. |
Founded in 2,001 |
Market share Second largest healthcare delivery chain in India by revenue with strong presence in North India and key metros Mumbai and Delhi NCR. |
Problem solved Provides access to high-quality, affordable healthcare services across various specialties including oncology, cardiac, neurosciences and orthopaedics. |
Top clients or who we serve Serves B2C patients, corporates, TPAs, institutional clients, and international patients through medical value travel programs. |
Key management Chairman and Managing Director: Mr. Abhay Soi; notable independent board members include experienced healthcare and industry leaders. |
Our journey and innovations Started in 2001; expanded through acquisitions and greenfield hospitals; introduced homecare (Max@Home) and diagnostic services (Max Labs); leading in robotic surgeries in India. |
Where we operate India-wide with focus in Delhi NCR, Mumbai, Mohali, Bathinda, Lucknow, Nagpur, Dehradun; international Patient Assistance Centres in 9 countries. |
Top products or what we offer Comprehensive hospital services including specialty and super specialty care, home health services, diagnostics, robotic surgeries, and transplant programs. |
Top brands Max Super Speciality Hospitals (multiple locations); Max@Home; Max Lab; BLK Hospital; Nanavati-Max Hospital; subsidiaries like Jaypee Healthcare. |
Raw materials needed Medical equipment, pharmaceuticals, diagnostic reagents, surgical consumables and hospital supplies. |
Raw materials supplier Global and local suppliers including major medical device and pharma companies. |
Recurring vs cyclical contribution Revenue is primarily recurring from hospital inpatient and outpatient services, with steady contribution from homecare and diagnostic segments. |
Our industry position Prominent market leader in tertiary and quaternary healthcare with strong brand recognition and robust financial performance. |
Financial highlights FY25 consolidated revenue ₹7,028 Cr, net profit ₹1,076 Cr; 4-year CAGR approx. 24% revenue growth; strong EBITDA margins around 26%. |
Geographical revenue split Majority revenue from Delhi NCR and Mumbai; growing presence in East and North India regions. |
Order book Ongoing expansions include new hospitals and brownfield capacity additions totaling ~10,000 beds over next 5 years. |
Whats driving growth Expansion of bed capacity, strategic acquisitions, digital health platforms, rising insurance penetration and medical tourism. |
Our future plans Add ~9,000 beds via brownfield and greenfield projects including asset-light models; expand Max@Home and Max Lab services. |
Our green promise ISO 14001 certified hospitals, water recycling, on-site solar installations, waste management; committed to 75% water neutrality. |
Our people and values 28,000+ employees; Great Place to Work certified; focus on employee wellbeing, training and diversity. |
Key challenges ahead Regulatory changes, rising costs of medical technologies, competitive healthcare market and maintaining high quality standards. |
Interesting facts Conducted over 6,600 robotic surgeries in FY25; operates Patient Assistance Centers across 9 countries facilitating medical tourism. |
Risks and strategy Risks from operational disruptions and regulatory policies mitigated by diversification, strong governance and clinical excellence. |
